COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines
On January 30, 2020, the WHO declared the novel coronavirus of 2019 a pandemic, causing millions of cases and thousands of deaths worldwide, exposing the vulnerabilities of healthcare systems around the world with each country having its own experience. These ranged from patient clinical profiles to...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Critical Care Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2021/7510306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223258697203712 |
|---|---|
| author | Onion Gerald V. Ubaldo Jose Emmanuel M. Palo Jude Erric L. Cinco |
| author_facet | Onion Gerald V. Ubaldo Jose Emmanuel M. Palo Jude Erric L. Cinco |
| author_sort | Onion Gerald V. Ubaldo |
| collection | DOAJ |
| description | On January 30, 2020, the WHO declared the novel coronavirus of 2019 a pandemic, causing millions of cases and thousands of deaths worldwide, exposing the vulnerabilities of healthcare systems around the world with each country having its own experience. These ranged from patient clinical profiles to management recommendations and to government interventions. There is a paucity of published data regarding Philippine experience. This study is a retrospective, descriptive study of ninety-one COVID-19 probable patients admitted in the COVID ICU of The Medical City from March 16 to May 7, 2020. We described clinical and demographic characteristics amongst COVID-19-confirmed and -negative patients. Therapeutic interventions including COVID-19 investigational drug use and other organ failure strategies were noted and tested for association with ICU survivors and nonsurvivors. We observed that there was no therapeutic intervention that was associated with improved outcomes, with some interventions showing trends favoring the ICU nonsurvivor group. These interventions include, but are not limited to, the use of hydroxychloroquine and tocilizumab, and prone positioning. We also observed that a higher SAPS-3 score was associated with the COVID-19 positive group and the ICU nonsurvivor group. On PubMed search, there seems to be no Philippine-specific literature regarding COVID-19 ICU experience. Further investigations to include more variables are recommended. |
| format | Article |
| id | doaj-art-5da94432c8f040038c8eddc06764e454 |
| institution | OA Journals |
| issn | 2090-1305 2090-1313 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Critical Care Research and Practice |
| spelling | doaj-art-5da94432c8f040038c8eddc06764e4542025-08-20T02:06:01ZengWileyCritical Care Research and Practice2090-13052090-13132021-01-01202110.1155/2021/75103067510306COVID-19: A Single-Center ICU Experience of the First Wave in the PhilippinesOnion Gerald V. Ubaldo0Jose Emmanuel M. Palo1Jude Erric L. Cinco2Acute and Critical Care Institute, The Medical City–Ortigas, Pasig City 1605, PhilippinesAcute and Critical Care Institute, The Medical City–Ortigas, Pasig City 1605, PhilippinesAcute and Critical Care Institute, The Medical City–Ortigas, Pasig City 1605, PhilippinesOn January 30, 2020, the WHO declared the novel coronavirus of 2019 a pandemic, causing millions of cases and thousands of deaths worldwide, exposing the vulnerabilities of healthcare systems around the world with each country having its own experience. These ranged from patient clinical profiles to management recommendations and to government interventions. There is a paucity of published data regarding Philippine experience. This study is a retrospective, descriptive study of ninety-one COVID-19 probable patients admitted in the COVID ICU of The Medical City from March 16 to May 7, 2020. We described clinical and demographic characteristics amongst COVID-19-confirmed and -negative patients. Therapeutic interventions including COVID-19 investigational drug use and other organ failure strategies were noted and tested for association with ICU survivors and nonsurvivors. We observed that there was no therapeutic intervention that was associated with improved outcomes, with some interventions showing trends favoring the ICU nonsurvivor group. These interventions include, but are not limited to, the use of hydroxychloroquine and tocilizumab, and prone positioning. We also observed that a higher SAPS-3 score was associated with the COVID-19 positive group and the ICU nonsurvivor group. On PubMed search, there seems to be no Philippine-specific literature regarding COVID-19 ICU experience. Further investigations to include more variables are recommended.http://dx.doi.org/10.1155/2021/7510306 |
| spellingShingle | Onion Gerald V. Ubaldo Jose Emmanuel M. Palo Jude Erric L. Cinco COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines Critical Care Research and Practice |
| title | COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines |
| title_full | COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines |
| title_fullStr | COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines |
| title_full_unstemmed | COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines |
| title_short | COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines |
| title_sort | covid 19 a single center icu experience of the first wave in the philippines |
| url | http://dx.doi.org/10.1155/2021/7510306 |
| work_keys_str_mv | AT oniongeraldvubaldo covid19asinglecentericuexperienceofthefirstwaveinthephilippines AT joseemmanuelmpalo covid19asinglecentericuexperienceofthefirstwaveinthephilippines AT judeerriclcinco covid19asinglecentericuexperienceofthefirstwaveinthephilippines |